Pantomath Capital is a full-fledged investment bank with a broad range of capital raising, M & A IPO listing programs and ranks as one of the leading investment banking firms in India
Our Capital Markets team offers rich expertise in handholding issuers who are seeking to finance growth, unlock value of the company, or reduce borrowing cost of their long-term strategic objectives.
One of India’s leading Investment Banker, we assist companies in raising capital from the public, and to date have raised more than INR 2,000+ CR from IPOs and FPOs in a very short span of 8 years.
We offer an innovative and out of the box approach to our clients, and our rich experience in deal closure, along with strong connections with various investors has enabled us to execute transactions in a challenging time frame
We assist in fund raising through rights issues, and private placement of shares including High Networth Individuals (HNIs) investors, Qualified Institutional Buyers, Corporate Treasuries, and Institutions
We offer post listing corporate action services like Delisting, Open Offer, Bonus Issue and Buy Backs which involves buying shares from the existing shareholders, managing takeovers and assisting acquirer to seamlessly complete the open offer process, assistance in getting a company delisted once it decided to go private again.
Critical energy transition equipment and power technologies company Successfully raised ₹850 Cr Via IPO , backed by 21 marquee anchor investor, premium listing in turbulent times, full subscription from QIBs, HNIs, and retail investors despite heavy secondary market sell-offs.
Sole Book Running Lead Manager
One of the prominent and multifaceted organization in the manufacturing of ERW steel tubes and pipes company Raised ₹ 5,000 MN through QIP, Overwhelming response with bids over ₹ 8,000 MN by marquee domestic & international institutional investors
Sole Book Running Lead Manager
Plant based speciality products company raised ₹ 5,100 MN via IPO, Issue was subscribed ~83x, QIB & HNIs subscribed 145.68 & 136.49 times, Garnered INR ~30,000 Crores
Sole Book Running Lead Manager
Manufacturer of High Purity Speciality Fine Chemicals Company Raised ₹ 1301 MN via IPO, Issue was subscribed ~117x, QIB subscribed ~89 Times, Garnered INR ~10600 Crores
Sole Book Running Lead Manager
Flexible flow manufacturing company raised ₹ 4270 MN via IPO, Issue was subscribed ~97x, QIB subscribed ~194x and garnered over ₹ 2,45,000 MN
Sole Book Running Lead Manager
One of the leading EPC player raised ₹ 3740 MN via IPO, Issue was subscribed ~87x, QIB subscribed ~171x and garnered over ₹ 1,91,500 MN
Co-Book Running Lead Manager
We act as trusted independent advisors to board and management of middle market companies in assessing strategic alternatives. We have rich experience and deep connections with strategic buyers and sellers across 20+ industries to host plethora of opportunities for our clients.
Has your strategic objective to increase market share, revenue enhancement and diversification, capacity expansion, or access to intellectual property has led you to buy another company?
We offer strategies and potential targets for you that suits your acquisition criteria, by taking a holistic approach beginning with your overall corporate strategy
To successfully sell (full or in parts) or recapitalize the company, along with it offer the right value to the business owners, and supports a smooth transition, are the benchmarks in a sell side transactions.
Our senior executive team who has the transaction acumen and right mix of talent will be your side throughout the stages of the transaction and strive to offer the right value of business to you.
Advised recyplast GmbH on their acquisition by con-pearl GmbH, part of the private equity company Blue Cap AG
Investment Banker to the Transaction
Advised on the sale of Romplast to the Bachl Group, which manufactures high-quality regranulates from used plastic foils
Investment Banker to the Transaction
Advised Performance54 on their partial exit to a strategic investor
Investment Banker to the Transaction
Advised Auvergne-based family group EHDH on the acquisition of Movianto, creating a European leader in pharmaceutical transport and logistics
Investment Banker to the Transaction
Advised Recipharm AB, a leading pharma CDMO, on its Joint Venture with long-term Indian partner Sobti family (India)
Exclusive advisor for the inbound investment
NASDAQ listed Caesarstone Limited, a global leader in the premium quartz industry acquired majority stake in Gujarat based Lioli Ceramica
Exculsive Investmemt Banker to the transaction
We seek to bridge the gap between your business and growth capital, to increase liquidity, finance value accretive capital expenditure, and Our strong relationships with alternative asset managers enable us to source private capital from single and multi-family offices, sovereign wealth funds, private equity firms, hedge funds and other institutional investors
Consumer Electricals Company closed private placement round of INR 200 Crores (USD 24 Mn)
Exclusive investment banker to the transaction
Acted as lead advisors to the shareholders of leading independent B2B agency The Marketing Practice (“TMP”) on their investment from Horizon Capital (“Horizon”)
Investment Banker to the Transaction
Advised specialist pharmaceutical biotech company Biotherapy Services Ltd (“BTS”) on their Series A fundraising, invested by Foresight Group
Investment Banker to the Transaction
EV charging solutions provider raised ₹ 1,200 MN ($ 15 MN) in Series A round, by Dr. Kiran C. Patel, a serial entrepreneur and philanthropist
Exclusive Investment Banker to the transaction
One of the leading manufacturers of wet processing equipment which manufactures artificial sand, raised pre IPO funds from IIFL Asset Management
Exclusive Investment Banker to the transaction
Pantomath’s Valuation Division is one of the leading valuation and financial advisory services group. Our valuation team has deep industry expertise and we have executed a wide variety of valuation engagements.
Our valuation team offers valuation services as required under various statues eg., Income-tax law, Companies law, FEMA, SEBI law, and also event-based business valuations to name few. We have earned confidence of corporates, investors, auditors and professionals with our result driven approach and well-documented reports that have consistently stood up to the highest standards of scrutiny.
Our foundation is built upon the commitment and credentials of our senior professionals who include CFAs, CAs, MBAs and CSs having relevant expertise in diverse financial and tax advisory roles.
We have completed 500+ valuation projects.
90% of our valuation clients won through referrals and / or repeat clients
Clients – from start-ups to established global conglomerates and large listed corporates, across wide spectrum of industries turn to Pantomath for valuation services across complex issues.
With rich and diverse experience in valuations along with various in-house data research facilities with a backup of strong analytical capabilities.
We provide meticulous, independent financial and valuation opinions that have withstood scrutiny from public and private company shareholders, corporate Boards of Directors and Special Committees, and regulatory authorities concerned.
Our foundation is built upon the commitment and credentials of our senior professionals who include CFAs, CAs, MBAs and CSs having relevant expertise in diverse financial and tax advisory roles.
We have completed 500+ valuation projects.
90% of our valuation clients won through referrals and / or repeat clients
Clients – from start-ups to established global conglomerates and large listed corporates, across wide spectrum of industries turn to Pantomath for valuation services across complex issues.
With rich and diverse experience in valuations along with various in-house data research facilities with a backup of strong analytical capabilities.
We provide meticulous, independent financial and valuation opinions that have withstood scrutiny from public and private company shareholders, corporate Boards of Directors and Special Committees, and regulatory authorities concerned.